Fuminari Misawa, MD, PhD

  • 3Articles
  • 20.2KReads
  • 2004–2022Active
  • 16Collaborators
  • 51Citations

About

Fuminari Misawa, MD, PhD, is affiliated with Yamanashi Prefectural Kita Hospital in Yamanashi, Japan. Misawa has published extensively on psychiatric topics, focusing on schizophrenia and schizoaffective disorders, as well as tardive dyskinesia. Their work includes analyses of antipsychotic treatments, neuroleptic malignant syndrome outcomes, and metabolic side effects such as hyperglycemia in patients receiving olanzapine. Misawa has collaborated frequently with Yasuo Fujii, Christoph U. Correll, Daniel Guinart, Fumio Koshiishi, and Georgios Schoretsanitis.

Publications

JCP
Tardive Dyskinesia and Long-Acting Injectable Antipsychotics
Original Research

Tardive Dyskinesia and Long-Acting Injectable Antipsychotics

August 3, 2022

This study compared spontaneous reporting of tardive dyskinesia with long-acting injectable versus oral antipsychotics.
, ,
JCP
Review Article

Outcomes of NMS With Depot Versus Oral Antipsychotics

November 24, 2020

Is the advantage of longer-term medication release with long-acting injectable antipsychotics offset by an increased risk of more prolonged and severe neuroleptic malignant syndrome? This systematic review and pooled...
, , , et al
JCP
Letter to the Editor

The Incidence of Hyperglycemia in Patients Treated With Olanzapine

March 1, 2004

, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe